Tag: Prevencio

Prevencio Announces Highly Accurate, AI-driven Blood Test with High Sensitivity (hs) Cardiac Troponin for the Diagnosis of Heart Disease

HART CADhs test addresses up to 30% of Emergency Department (ED) chest pain patients who cannot safely be ruled-in nor ruled-out for heart attack KIRKLAND, Wash.–(BUSINESS WIRE)–Prevencio, Inc. today announces data confirming the high accuracy of its AI-driven, multiple-protein HART CADhs […]

Prevencio Announces Two Additional Peer-reviewed Manuscripts for Novel HART Tests Using AI-driven Approach

KIRKLAND, Wash.–(BUSINESS WIRE)–Prevencio, Inc., announces publication of data for two more tests, HART AS and HART AKI, in its expanding pipeline of multi-protein, AI-driven tests for cardiovascular disease and related conditions. The HART AS data was presented at the 2018 American College […]

New Prevencio Study Using AI Demonstrates Novel Blood Test Accurately Predicts Acute Kidney Injury (AKI) Risk

KIRKLAND, Wash.–(BUSINESS WIRE)–Prevencio, Inc. today announces data demonstrating high accuracy for its multiple-protein HART AKITM test. Researchers believe these important findings, presented November 10 at the 2018 American Heart Association (AHA) Scientific Sessions in Chicago, will lead to more accurate prediction […]

Prevencio Announces Data Demonstrating HART PAD™ Blood Test Accurately Diagnoses Peripheral Artery Disease in Diabetic Patients

KIRKLAND, Wash., Aug. 27, 2018 /PRNewswire/ — Prevencio, Inc. today announces data demonstrating its HART PAD™test accurately diagnoses peripheral artery disease (PAD) in diabetes mellitus (DM) patients, a patient population in which PAD prevalence has traditionally been difficult to assess. Researchers believe these […]

Clinical Cardiology Publishes Study Demonstrating Simple Blood Test from Prevencio Accurately Detects Cardiovascular Disease

KIRKLAND, Wash.–(BUSINESS WIRE)–Prevencio, Inc., announces the publication of data that demonstrates a simple new blood test accurately diagnoses significant Peripheral Artery Disease (PAD), a circulatory problem in which plaque-narrowed arteries reduce blood flow to a patient’s limbs and kidneys. If […]

New Prevencio Study Using AI Determines Simple Blood Tests Accurately Diagnose Heart Disease and Predict Adverse Heart Events in Diabetic Patients

KIRKLAND, Wash.–(BUSINESS WIRE)–Prevencio, Inc. today announces data which indicates its HART CAD and HART CVE tests accurately diagnose Coronary Artery Disease (CAD) and risk for Major Adverse Cardiac Events (MACE) in Diabetic Mellitus (DM) patients. Researchers believe the data, presented […]